Publications by authors named "Roger Blain"

Claim this Profile
I
In vitro and in vivo activity of R547: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials.
Wanda DePinto, Xin-Jie Chu, Xuefeng Yin, Melissa Smith, Kathryn Packman, Roger Blain

Mol Cancer Ther· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, safety, and tolerability of R411, a dual alpha4beta1-alpha4beta7 integrin antagonist after oral administration at single and multiple once-daily ascending doses in healthy volunteers.
Youssef Hijazi, Horst Welker, Albert E Dorr, Jian-Ping Tang, Roger Blain

J Clin Pharmacol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis